Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
Shanafelt TD, Lin T, Geyer SM, et al. (June 2007). „Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemia”. Cancer109 (11): 2291–8. DOI:10.1002/cncr.22662. PMID17514743.
Young SD, Whissell M, Noble JC, et al. (2006). „Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors”. Clinical Cancer Research12 (10): 3092–8. DOI:10.1158/1078-0432.CCR-05-2255. PMID16707607.
Makhani N, Gorman MP, Branson HM, et al. (June 2009). „Cyclophosphamide therapy in pediatric multiple sclerosis”. Neurology volume=7272 (24): 2076–82. DOI:10.1212/WNL.0b013e3181a8164c. PMID19439723.
Shanafelt TD, Lin T, Geyer SM, et al. (June 2007). „Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemia”. Cancer109 (11): 2291–8. DOI:10.1002/cncr.22662. PMID17514743.
Young SD, Whissell M, Noble JC, et al. (2006). „Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors”. Clinical Cancer Research12 (10): 3092–8. DOI:10.1158/1078-0432.CCR-05-2255. PMID16707607.
Townes AS, Sowa JM, Shulman LE (May 1976). „Controlled trial of cyclophosphamide in rheumatoid arthritis”. Arthritis & Rheumatism19 (3): 563–73. PMID779796.
Novack SN, Pearson CM. (April 1971). „Cyclophosphamide therapy in Wegener's granulomatosis”. New England Journal of Medicine284 (17): 938–42. PMID5551803.
Makhani N, Gorman MP, Branson HM, et al. (June 2009). „Cyclophosphamide therapy in pediatric multiple sclerosis”. Neurology volume=7272 (24): 2076–82. DOI:10.1212/WNL.0b013e3181a8164c. PMID19439723.